93 related articles for article (PubMed ID: 18260972)
1. [Metalloproteinase activity of the blood in patients with arterial hypertension with paroxysmal form of atrial fibrillation].
Khezheva FM; Mazur NA; Masenko VP
Kardiologiia; 2007; 47(12):10-4. PubMed ID: 18260972
[TBL] [Abstract][Full Text] [Related]
2. Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.
Tayebjee MH; Nadar SK; MacFadyen RJ; Lip GY
Am J Hypertens; 2004 Sep; 17(9):770-4. PubMed ID: 15363818
[TBL] [Abstract][Full Text] [Related]
3. Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?
Marín F; Roldán V; Climent V; Garcia A; Marco P; Lip GY
Stroke; 2003 May; 34(5):1181-6. PubMed ID: 12663879
[TBL] [Abstract][Full Text] [Related]
4. Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.
Hansson J; Lind L; Hulthe J; Sundström J
Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):297-303. PubMed ID: 19387352
[TBL] [Abstract][Full Text] [Related]
5. Circulating tissue inhibitor of matrix metalloproteinase-1 is associated with aldosterone-induced diastolic dysfunction.
Hung CS; Chou CH; Wu XM; Chang YY; Wu VC; Chen YH; Chang YS; Tsai YC; Su MJ; Ho YL; Chen MF; Wu KD; Lin YH;
J Hypertens; 2015 Sep; 33(9):1922-30; discussion 1930. PubMed ID: 26103125
[TBL] [Abstract][Full Text] [Related]
6. The impact of hypertension and hypertension-related left ventricle hypertrophy on right ventricle function.
Tumuklu MM; Erkorkmaz U; Ocal A
Echocardiography; 2007 Apr; 24(4):374-84. PubMed ID: 17381646
[TBL] [Abstract][Full Text] [Related]
7. [Effect of hypotensive therapy on metalloproteinase activity of the blood in patients with arterial hypertension].
Mazur NA; Khezheva FM
Kardiologiia; 2009; 49(2):27-31. PubMed ID: 19254213
[TBL] [Abstract][Full Text] [Related]
8. Relationship between left ventricular twist and circulating biomarkers of collagen turnover in hypertensive patients with heart failure.
Maharaj N; Khandheria BK; Libhaber E; Govender S; Duarte R; Peters F; Essop MR
J Am Soc Echocardiogr; 2014 Oct; 27(10):1064-71. PubMed ID: 24944140
[TBL] [Abstract][Full Text] [Related]
9. MMP-9 in atrial remodeling in patients with atrial fibrillation.
Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
[TBL] [Abstract][Full Text] [Related]
10. [Ventricular remodeling and matrix metalloproteinase-1 and its tissue inhibitor of metalloproteinase-1 in serum in third trimester of pregnant women with cardiac disease.].
Zhang ZL; Lin JH; Tao RQ
Zhonghua Fu Chan Ke Za Zhi; 2009 Oct; 44(10):731-5. PubMed ID: 20078957
[TBL] [Abstract][Full Text] [Related]
11. [The role of tissue myocardial dopplerechocardiography in early detection of structural-functional changes in the myocardium of patients with mild and moderate arterial hypertension].
Saidova MA; Shitov VN; Guseĭnova BA; Blinova EV; Chikhladze NM; Sivakova OA; Chazova IE
Ter Arkh; 2008; 80(4):21-8. PubMed ID: 18491575
[TBL] [Abstract][Full Text] [Related]
12. The signal-averaged P-wave duration is longer in hypertensive patients with history of paroxysmal atrial fibrillation as compared to those without.
Aytemir K; Amasyali B; Abali G; Kose S; Kilic A; Onalan O; Tokgozoglu L; Kabakci G; Ozkutlu H; Nazli N; Isik E; Oto A
Int J Cardiol; 2005 Aug; 103(1):37-40. PubMed ID: 16061121
[TBL] [Abstract][Full Text] [Related]
13. Left ventricular remodeling, mechanics, and tissue characterization in congenital aortic stenosis.
Pacileo G; Calabrò P; Limongelli G; Russo MG; Pisacane C; Sarubbi B; Calabrò R
J Am Soc Echocardiogr; 2003 Mar; 16(3):214-20. PubMed ID: 12618728
[TBL] [Abstract][Full Text] [Related]
14. Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension.
Tan J; Hua Q; Xing X; Wen J; Liu R; Yang Z
Hypertens Res; 2007 Oct; 30(10):959-63. PubMed ID: 18049028
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
16. [Matrix metalloproteinases: significance in remodeling of the myocardium in valvular heart disease].
Goncharova NS; Moiseeva OM; Shliakhto EV; Aleshina GM
Kardiologiia; 2007; 47(12):49-52. PubMed ID: 18260979
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum markers for collagen synthesis in patients with hypertrophic cardiomyopathy and diastolic dysfunction.
Fassbach M; Schwartzkopff B
Z Kardiol; 2005 May; 94(5):328-35. PubMed ID: 15868361
[TBL] [Abstract][Full Text] [Related]
18. [Echocardiographic assessment of myocardial fibrosis in young men with arterial hypertension and different types of left ventricular remodeling].
Kobalava ZhD; Kotovskaia IuV; Safarova AF; Moiseev VS
Kardiologiia; 2011; 51(2):34-9. PubMed ID: 21627596
[TBL] [Abstract][Full Text] [Related]
19. Effect of matrix metalloproteinase and their inhibitors on atrial myocardial structural remodeling.
Wang W; Zhang HT; Yang XL
J Cardiovasc Med (Hagerstown); 2013 Apr; 14(4):265-9. PubMed ID: 22929563
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation.
Anné W; Willems R; Roskams T; Sergeant P; Herijgers P; Holemans P; Ector H; Heidbüchel H
Cardiovasc Res; 2005 Sep; 67(4):655-66. PubMed ID: 15913581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
